Stay updated on Gemcitabine+Nivolumab in Metastatic Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Gemcitabine+Nivolumab in Metastatic Small Cell Lung Cancer Clinical Trial page.

Latest updates to the Gemcitabine+Nivolumab in Metastatic Small Cell Lung Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page now states that enrollment is closed (no longer looking for participants) and adds new user-guidance sections such as How to Read a Study Record, Common Questions, and How to Join a Study; the older Intervention / Treatment heading and the Revision: v3.5.5 tag were removed.SummaryDifference0.5%

- Check9 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, reflecting a minor update to the page’s rendering/versioning.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedThe page shows a new revision number (v3.5.4) replacing the previous version. This indicates a minor update to the page documentation rather than changes to trial details.SummaryDifference0.1%

- Check52 days agoChange DetectedClinicalTrials.gov’s page footer revision was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check59 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check88 days agoChange DetectedRevision metadata updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Gemcitabine+Nivolumab in Metastatic Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gemcitabine+Nivolumab in Metastatic Small Cell Lung Cancer Clinical Trial page.